谷氨酰胺
免疫疗法
规范化(社会学)
新陈代谢
癌症研究
计算生物学
化学
医学
药理学
细胞生物学
生物化学
生物信息学
生物
免疫学
免疫系统
社会学
氨基酸
人类学
作者
Yunfei Yi,Zhangwen Peng,Yuanqi Liu,Huisong Hao,Yu Liu,Simin Wen,Shengjie Sun,Jianlin Shi,Meiying Wu,Lin Mei
标识
DOI:10.1016/j.apsb.2025.02.020
摘要
Among tumor microenvironment (TME), the entire metabolic characteristics of tumor-resident cells are reprogrammed to benefit the expansion of tumor cells, which count on glutamine in large part to fuel the tricarboxylic acid cycle for energy generation and anabolic metabolism support. Endothelial cells that are abducted by tumor cells to form a pathological tumor vascular network for constructing the hypoxic immunosuppressive TME, also rely on glutaminolysis as the "engine" of angiogenesis. Additionally, the glutamine metabolic preference benefits the polarization of TAMs towards pro-tumoral M2 phenotype as well. Herein, we developed a type of siRNA micelleplexes (MH@siGLS1) to reverse immunosuppressive TME by targeting glutaminolysis within tumor-resident cells for tumor vasculature normalization- and TAMs repolarization-enhanced photo-immunotherapy. Tumor cell starvation and antioxidant system destruction achieved by MH@siGLS1-mediated glutaminolysis inhibition could promote photodynamic therapy efficacy, which was available to trigger immunogenic cell death for adaptive antitumor immune responses. Meanwhile, glutaminolysis inhibition of tumor endothelial cells and TAMs could realize tumor vascular normalization and TAMs repolarization for antitumor immunity amplification. This study provides a unique perspective on cancer treatments by focusing on the interrelations of metabolic characteristics and the biofunctions of various cell types within TME.
科研通智能强力驱动
Strongly Powered by AbleSci AI